{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:53:22Z","timestamp":1778165602617,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"UCB Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s40744-020-00214-7","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T09:02:42Z","timestamp":1591866162000},"page":"581-599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE"],"prefix":"10.1007","volume":"7","author":[{"given":"Robert","family":"Landew\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Van den Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Hoepken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"de Peyrecave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianne S.","family":"Gensler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"214_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1759720X12468658","volume":"5","author":"D Poddubnyy","year":"2013","unstructured":"Poddubnyy D. Axial spondyloarthritis: is there a treatment of choice? Ther Adv Musculoskelet Dis. 2013;5:45\u201354.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"214_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13075-017-1493-8","volume":"19","author":"N Ghosh","year":"2017","unstructured":"Ghosh N, Ruderman EM. Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance. Arthritis Res Ther. 2017;19:286.","journal-title":"Arthritis Res Ther"},{"key":"214_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/annrheumdis-2015-208852","volume":"75","author":"A Deodhar","year":"2016","unstructured":"Deodhar A, Strand V, Kay J, et al. The term \u2018non-radiographic axial spondyloarthritis\u2019 is much more important to classify than to diagnose patients with axial spondyloarthritis. Ann Rheum Dis. 2016;75:791\u20134.","journal-title":"Ann Rheum Dis"},{"key":"214_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/acr2.11044","volume":"1","author":"MA Khan","year":"2019","unstructured":"Khan MA, van der Linden S. Axial spondyloarthritis: a better name for an old disease: a step toward uniform reporting. ACR Open Rheumatol. 2019;1:336\u20139.","journal-title":"ACR Open Rheumatol"},{"key":"214_CR5","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1002\/art.38140","volume":"65","author":"A Ciurea","year":"2013","unstructured":"Ciurea A, Scherer A, Exer P, et al. Tumor necrosis factor alpha inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum. 2013;65:3096\u2013106.","journal-title":"Arthritis Rheum"},{"key":"214_CR6","doi-asserted-by":"publisher","first-page":"e001108","DOI":"10.1136\/rmdopen-2019-001108","volume":"5","author":"C L\u00f3pez-Medina","year":"2019","unstructured":"L\u00f3pez-Medina C, Ramiro S, van der Heijde D, et al. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019;5:e001108.","journal-title":"RMD Open"},{"key":"214_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller E, Khan MA, van der Heijde D, et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003;23:61\u20136.","journal-title":"Rheumatol Int"},{"key":"214_CR8","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/rheumatology\/kez090","volume":"58","author":"I Redeker","year":"2019","unstructured":"Redeker I, Callhoff J, Hoffmann F, et al. Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. Rheumatology. 2019;58:1634\u20138.","journal-title":"Rheumatology"},{"key":"214_CR9","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1136\/annrheumdis-2013-204867","volume":"74","author":"J S\u00f8rensen","year":"2015","unstructured":"S\u00f8rensen J, Hetland ML, All departments of rheumatology in Denmark. Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry. Ann Rheum Dis. 2015;74:e12.","journal-title":"Ann Rheum Dis"},{"key":"214_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10067-018-4397-3","volume":"38","author":"A Danve","year":"2019","unstructured":"Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clin Rheumatol. 2019;38:625\u201334.","journal-title":"Clin Rheumatol"},{"key":"214_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jbspin.2016.06.005","volume":"84","author":"V Masson Behar","year":"2017","unstructured":"Masson Behar V, Dougados M, Etcheto A, et al. Diagnostic delay in axial spondyloarthritis: a cross-sectional study of 432 patients. Jt Bone Spine. 2017;84:467\u201371.","journal-title":"Jt Bone Spine"},{"key":"214_CR12","first-page":"2283","volume":"54","author":"MP Sykes","year":"2015","unstructured":"Sykes MP, Doll H, Sengupta R, et al. Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? Rheumatology. 2015;54:2283\u20134.","journal-title":"Rheumatology"},{"key":"214_CR13","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, et al. 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2019;71:1599\u2013613.","journal-title":"Arthritis Rheumatol"},{"key":"214_CR14","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/rheumatology\/kex174","volume":"56","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Dougados M, Landewe R, et al. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA. Rheumatology. 2017;56:1498\u2013509.","journal-title":"Rheumatology"},{"key":"214_CR15","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/rheumatology\/kew464","volume":"56","author":"CJ Edwards","year":"2017","unstructured":"Edwards CJ, Fautrel B, Schulze-Koops H, et al. Dosing down with biologic therapies: a systematic review and clinicians\u2019 perspective. Rheumatology. 2017;56:1847\u201356.","journal-title":"Rheumatology"},{"key":"214_CR16","doi-asserted-by":"crossref","unstructured":"Hindryckx P, Zou GY, Feagan BG, et al. Biologic drugs for induction and maintenance of remission in Crohn\u2019s disease: a network meta\u2010analysis. Cochrane Database Syst Rev 2017;2017.","DOI":"10.1002\/14651858.CD012751"},{"key":"214_CR17","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1316133","volume":"371","author":"P Emery","year":"2014","unstructured":"Emery P, Hammoudeh M, FitzGerald O, et al. Sustained remission with etanercept tapering in early rheumatoid arthritis. N Engl J Med. 2014;371:1781\u201392.","journal-title":"N Engl J Med"},{"key":"214_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0140-6736(18)31362-X","volume":"392","author":"R Landew\u00e9","year":"2018","unstructured":"Landew\u00e9 R, Sieper J, Mease P, et al. Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study. Lancet. 2018;392:134\u201344.","journal-title":"Lancet"},{"key":"214_CR19","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/rheumatology\/kew033","volume":"55","author":"V Navarro-Compan","year":"2016","unstructured":"Navarro-Compan V, Plasencia-Rodriguez C, de Miguel E, et al. Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review. Rheumatology. 2016;55:1188\u201394.","journal-title":"Rheumatology"},{"key":"214_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/OARRR.S116654","volume":"10","author":"J Marin","year":"2018","unstructured":"Marin J, Acosta Felquer ML, Soriano ER. Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy. Open Access Rheumatol. 2018;10:33\u201341.","journal-title":"Open Access Rheumatol"},{"key":"214_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.40866","volume":"71","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Gensler LS, Kay J, et al. A fifty-two-week, randomized, placebo-controlled trial of certolizumab pegol in nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2019;71:1101\u201311.","journal-title":"Arthritis Rheumatol"},{"key":"214_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216839","author":"R Landew\u00e9","year":"2019","unstructured":"Landew\u00e9 R, van der Heijde D, Dougados M, et al. Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction. Ann Rheum Dis. 2020.  https:\/\/doi.org\/10.1136\/annrheumdis-2019-216839.","journal-title":"Ann Rheum Dis"},{"key":"214_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011;70:47\u201353.","journal-title":"Ann Rheum Dis"},{"key":"214_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","volume":"77","author":"PM Machado","year":"2018","unstructured":"Machado PM, Landew\u00e9 R, van der Heijde D. Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states. Ann Rheum Dis. 2018;77:1539\u201340.","journal-title":"Ann Rheum Dis"},{"key":"214_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70:25\u201331.","journal-title":"Ann Rheum Dis"},{"key":"214_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361\u20138.","journal-title":"Arthritis Rheum"},{"key":"214_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.62.1.20","volume":"62","author":"LC Doward","year":"2003","unstructured":"Doward LC, Spoorenberg A, Cook SA, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis. 2003;62:20\u20136.","journal-title":"Ann Rheum Dis"},{"key":"214_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"214_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/art.21445","volume":"53","author":"WP Maksymowych","year":"2005","unstructured":"Maksymowych WP, Inman RD, Salonen D, et al. Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Care Res. 2005;53:703\u20139.","journal-title":"Arthritis Care Res"},{"key":"214_CR30","doi-asserted-by":"publisher","first-page":"vi18","DOI":"10.1093\/rheumatology\/key176","volume":"57","author":"H Marzo-Ortega","year":"2018","unstructured":"Marzo-Ortega H, Gaffney K, Gaffney K. Defining the target: clinical aims in axial spondyloarthritis. Rheumatology. 2018;57:vi18\u2013vi22.","journal-title":"Rheumatology"},{"key":"214_CR31","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978.","journal-title":"Ann Rheum Dis"},{"key":"214_CR32","doi-asserted-by":"publisher","first-page":"R164","DOI":"10.1186\/ar4680","volume":"16","author":"JT Osterhaus","year":"2014","unstructured":"Osterhaus JT, Purcaru O. Discriminant validity, responsiveness and reliability of the arthritis-specific work productivity survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis. Arthritis Res Ther. 2014;16:R164.","journal-title":"Arthritis Res Ther"},{"key":"214_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/RHU.0000000000000589","volume":"23","author":"V Strand","year":"2017","unstructured":"Strand V, Singh JA. Patient burden of axial spondyloarthritis. J Clin Rheumatol. 2017;23:383\u201391.","journal-title":"J Clin Rheumatol"},{"key":"214_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jbspin.2019.04.006","volume":"87","author":"K Aouad","year":"2019","unstructured":"Aouad K, Ziade N, Baraliakos X. Structural progression in axial spondyloarthritis. Jt Bone Spine. 2019;87:131\u20136.","journal-title":"Jt Bone Spine"},{"key":"214_CR35","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/acr.23796","volume":"71","author":"S Ramiro","year":"2019","unstructured":"Ramiro S, van der Heijde D, Sepriano A, et al. Spinal radiographic progression in early axial spondyloarthritis: five-year results from the DESIR cohort. Arthritis Care Res. 2019;71:1678\u201384.","journal-title":"Arthritis Care Res"},{"key":"214_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2013-204231","volume":"73","author":"R Landew\u00e9","year":"2014","unstructured":"Landew\u00e9 R, Braun J, Deodhar A, et al. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled phase 3 study. Ann Rheum Dis. 2014;73:39\u201347.","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00214-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-020-00214-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00214-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T10:18:33Z","timestamp":1714731513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-020-00214-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1007\/s40744-020-00214-7","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}